Thoracic Stent Graft Treats Aortic Dissections
By HospiMedica International staff writers Posted on 23 Mar 2014 |
Image: The Valiant Captivia Thoracic Stent Graft System (Photo courtesy of Medtronic).
An innovative stent graft system has been expanded to treat dangerous tears in the upper segment of the body's main artery.
The Valiant Captivia Thoracic Stent Graft System can now be used for the treatment of type B aortic dissections, a serious cardiovascular condition associated with high morbidity and mortality in which the upper segment of the aorta has become torn along the innermost layer of the vessel wall. The system features a unique proximal tip-capture mechanism, which enables controlled deployment and accurate placement of the stent graft, as well as complete apposition to the vessel wall, regardless of angulations or over-sizing.
The size matrix of the Valiant Captivia Thoracic Stent Graft System has been expanded, with 11 new proximal FreeFlo tapered pieces, increasing configuration possibilities by 30% to address a wider range of patient anatomies. The line extension enables physicians to use the system in tapered aortas, which account for approximately 20% of all thoracic aortic aneurysm cases. The new pieces all taper by 4 mm along their approximately 150-mm length, and have proximal diameters that range from 26–46 mm.
The Valiant Captivia Thoracic Stent Graft System is a product of Medtronic (Minneapolis, MN, USA), and has been implanted in over 50,000 patients world-wide since its initial 2005 launch in Europe. The additional system components for the treatment of aortic dissection have recently been approved by the US Food and Drug Administration (FDA) as well as receiving the Conformité Européene (CE) marking of approval, following several important studies.
“Acute type B aortic dissection is a potentially life-threatening condition that historically has been treated with either medical therapy or, when necessary, through invasive surgical techniques,” said Joseph Bavaria, MD, professor of surgery, director of the thoracic aortic surgery program at the University of Pennsylvania (Philadelphia, USA), and principal investigator of the DISSECTION study. “The trial we conducted shows that endovascular repair with the Valiant Captivia System provides a safe, effective and potentially life-saving treatment option for acute dissection patients.”
“The anatomy of the thoracic aorta is complex and unique to every individual,” said Matt Thompson, MD, professor of vascular surgery at St. George's Hospital (London, United Kingdom) and primary investigator for the MOTHER registry study. “For patients with tapered aortas, thoracic endovascular aortic repair is not always straightforward and requires careful device sizing to ensure treatment success. The addition of tapered pieces to the Valiant Captivia System provides physicians with more options to confidently and effectively accommodate both straightforward and challenging anatomies.”
Related Links:
Medtronic
University of Pennsylvania
St. George's Hospital
The Valiant Captivia Thoracic Stent Graft System can now be used for the treatment of type B aortic dissections, a serious cardiovascular condition associated with high morbidity and mortality in which the upper segment of the aorta has become torn along the innermost layer of the vessel wall. The system features a unique proximal tip-capture mechanism, which enables controlled deployment and accurate placement of the stent graft, as well as complete apposition to the vessel wall, regardless of angulations or over-sizing.
The size matrix of the Valiant Captivia Thoracic Stent Graft System has been expanded, with 11 new proximal FreeFlo tapered pieces, increasing configuration possibilities by 30% to address a wider range of patient anatomies. The line extension enables physicians to use the system in tapered aortas, which account for approximately 20% of all thoracic aortic aneurysm cases. The new pieces all taper by 4 mm along their approximately 150-mm length, and have proximal diameters that range from 26–46 mm.
The Valiant Captivia Thoracic Stent Graft System is a product of Medtronic (Minneapolis, MN, USA), and has been implanted in over 50,000 patients world-wide since its initial 2005 launch in Europe. The additional system components for the treatment of aortic dissection have recently been approved by the US Food and Drug Administration (FDA) as well as receiving the Conformité Européene (CE) marking of approval, following several important studies.
“Acute type B aortic dissection is a potentially life-threatening condition that historically has been treated with either medical therapy or, when necessary, through invasive surgical techniques,” said Joseph Bavaria, MD, professor of surgery, director of the thoracic aortic surgery program at the University of Pennsylvania (Philadelphia, USA), and principal investigator of the DISSECTION study. “The trial we conducted shows that endovascular repair with the Valiant Captivia System provides a safe, effective and potentially life-saving treatment option for acute dissection patients.”
“The anatomy of the thoracic aorta is complex and unique to every individual,” said Matt Thompson, MD, professor of vascular surgery at St. George's Hospital (London, United Kingdom) and primary investigator for the MOTHER registry study. “For patients with tapered aortas, thoracic endovascular aortic repair is not always straightforward and requires careful device sizing to ensure treatment success. The addition of tapered pieces to the Valiant Captivia System provides physicians with more options to confidently and effectively accommodate both straightforward and challenging anatomies.”
Related Links:
Medtronic
University of Pennsylvania
St. George's Hospital
Latest Surgical Techniques News
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons